Keyphrases
Oral Administration
100%
Rheumatoid Arthritis
100%
Mouse Model
100%
Bovine Lactoferrin
100%
SKG Mouse
100%
Tumor Necrosis Factor-α
41%
Liposomal
41%
TRAF2
25%
Arthritis Models
16%
Bone Destruction
16%
Low-density Lipoprotein Receptor-related protein-1 (LRP1)
16%
Pathological Progression
16%
Mannan
16%
TRADD
16%
Autoimmune Disease
8%
In Vitro Study
8%
Signaling Pathway
8%
Small Interfering RNA (siRNA)
8%
Inhibitory Effect
8%
Dose Effect
8%
Mitogen-activated Protein Kinase
8%
Nuclear factor-κB
8%
Beneficial Effects
8%
Anti-inflammatory Effect
8%
Immunomodulatory Properties
8%
Downstream Signaling
8%
Anti-inflammatory Properties
8%
Spleen
8%
T Helper 17 (Th17)
8%
Regulatory T Cells
8%
Anti-tumor Necrosis Factor (anti-TNF)
8%
Knockdown
8%
Orally Administered
8%
Inflammatory Bone Disease
8%
TNF Receptor 2 (TNFR2)
8%
Adapter Protein
8%
Mouse Genetics
8%
Joint Swelling
8%
Rheumatoid Arthritis Patients
8%
Osteoclastic
8%
Multifunctional Protein
8%
Ubiquitin Ligase
8%
Ankle Joint
8%
Synovial Fibroblasts
8%
Pannus Formation
8%
Pannus
8%
Intracellular Accumulation
8%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Rheumatoid Arthritis
100%
Lactoferrin
100%
Inflammatory Arthritis
100%
Tumor Necrosis Factor
41%
Tumor Necrosis Factor Receptor Associated Factor 2
33%
Bone Destruction
25%
Mannan
16%
Pannus
16%
Autoimmune Disease
8%
Anti-Inflammatory Drug
8%
Antiinflammatory Activity
8%
Immunoglobulin Enhancer Binding Protein
8%
Arthritis
8%
Small Interfering RNA
8%
Mitogen Activated Protein Kinase
8%
Ubiquitin Protein Ligase
8%
Synapsin I
8%
Lipoprotein Receptor
8%
Joint Swelling
8%
Immunology and Microbiology